The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Biomaterials in myocardial tissue engineering: Biomaterials in myocardial tissue engineeringcpr
Open accessAbstract
Cardiovascular disease is the leading cause of death in the developed world, and as such there is a pressing need for treatment options. Cardiac tissue engineering emerged from the need to develop alternative sources and methods of replacing tissue damaged by cardiovascular diseases, as the ultimate treatment option for many who suffer from end-stage heart failure is a heart transplant. In this review we focus on biomaterial approaches to augmenting injured or impaired myocardium, with specific emphasis on: the design criteria for these biomaterials; the types of scaffolds - composed of natural or synthetic biomaterials or decellularized extracellular matrix - that have been used to develop cardiac patches and tissue models; methods to vascularize scaffolds and engineered tissue; and finally, injectable biomaterials (hydrogels) designed for endogenous repair, exogenous repair or as bulking agents to maintain ventricular geometry post-infarct. The challenges facing the field and obstacles that must be overcome to develop truly clinically viable cardiac therapies are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Eschenhagen, T., Fink, C., Remmers, U., Scholz, H., Wattchow, J., Weil, J., Zimmermann, W., Dohmen, H. H., Schäfer, H., Bishopric, N., et al. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.8.9240969 · Cited by 636
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue
Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., & Vunjak‐Novakovic, G. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20722 · Cited by 399
Self-citationPerfusable branching microvessel bed for vascularization of engineered tissues
Chiu, L. L. Y., Montgomery, M., Liang, Y., Liu, H., & Radisic, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210580109 · Cited by 171
Self-citationDevelopment of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model
Yildirim, Y., Naito, H., Didié, M., Karikkineth, B. C., Biermann, D., Eschenhagen, T., & Zimmermann, W.-H. (2007) · Circulation · doi:10.1161/circulationaha.106.679688 · Cited by 100
Cited by
Zhang, X., Chen, X., Hong, H., Hu, R., Liu, J., & Liu, C. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.014 · Cited by 680
Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Self-citationKapnisi, M., Mansfield, C., Marijon, C., Guex, A. G., Perbellini, F., Bardi, I., Humphrey, E. J., Puetzer, J. L., Mawad, D., Koutsogeorgis, D. C., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800618 · Cited by 278
Composite biomaterial scaffolds for cardiac tissue engineering
Shapira, A., Feiner, R., & Dvir, T. (2016) · International Materials Reviews · doi:10.1179/1743280415y.0000000012 · Cited by 114
Implantation strategy of tissue-engineered liver based on decellularized spleen matrix in rats
Liu (2018) · PubMed · doi:10.3969/j.issn.1673-4254.2018.06.09 · Cited by 2
Metadata
- Authors
- Reis, L. A., Chiu, L. L. Y., Feric, N., Fu, L., & Radisic, M.
- Venue
- Journal of Tissue Engineering and Regenerative Medicine
- Publisher
- Wiley
- Published
- 2014-07-28
- Volume
- 10
- Issue
- 1
- Pages
- 11-28
- ISSN
- 1932-6254 (ISSN-L)
- OpenAlex
- W1568001924
- Cited by
- 233
- References
- 6
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.